Multiple Sclerosis



Comparison of Two Community Based Exercise Protocols in People With Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:   Other: Personal training exercises
Sponsor:   Texas Woman's University
Recruiting


Efficacy of tDCS on Pain in Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Device: Real-tDCS + rehabilitation programme;   Device: Sham-tDCS + rehabilitation programme
Sponsor:   University Hospital of Ferrara
Recruiting


Multiple Sclerosis Registry in Argentina (RelevarEM)


Condition:   Multiple Sclerosis
Intervention:   Other: Natural history of disease
Sponsor:   Hospital Italiano de Buenos Aires
Not yet recruiting


Evaluation of the Onset of Action in Highly Active Multiple Sclerosis (MS)


Condition:   Multiple Sclerosis
Intervention:   Drug: Mavenclad®
Sponsor:   Merck KGaA
Not yet recruiting


Effects of Inspiratory Muscle Training in Persons With Advanced Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:   Other: Inspiratory Muscle Trainer (IMT)
Sponsors:   University of Michigan;   National Multiple Sclerosis Society
Recruiting


Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis


Condition:   Relapsing Remitting Multiple Sclerosis
Interventions:   Drug: Fingolimod;   Drug: Dimethyl Fumarate
Sponsors:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Patient-Centered Outcomes Research Institute;   Universita degli Studi di Genova
Recruiting


Early Exercise Efforts in Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Combination Product: Systematic exercise training;   Behavioral: Educational program
Sponsors:   University of Aarhus;   University of Southern Denmark;   Region of Southern Denmark
Not yet recruiting


Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab


Condition:   Relapsing Multiple Sclerosis
Interventions:   Drug: Ofatumumab subcutaneous injection;   Drug: Placebo subcutaneous injection matching ofatumumab
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting


Obstetric Anesthesia and Analgesia and Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:   Other: Data search
Sponsors:   Brno University Hospital;   Faculty of medicine, Masaryk University Brno
Completed


Physical Telerehabilitation in Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Other: Home telerehabilitation;   Other: Usual Care
Sponsors:   Columbia University;   United States Department of Defense
Recruiting


Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study


Condition:   Multiple Sclerosis
Interventions:   Drug: Interferon beta-1b (Betaferon, BAY86-5046);   Device: Betaconnect auto-injector;   Device: myBETAapp
Sponsor:   Bayer
Recruiting


Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Biological: Autologous Hematopoietic Stem Cell;   Drug: BEAM Regimen
Sponsor:   Makati Medical Center
Recruiting


Use of the Nine Holes Peg Test in Multiple Sclerosis: Participation of Elementary Neurological Components in the Functional Evaluation of Manual Dexterity


Condition:   Multiple Sclerosis
Interventions:   Diagnostic Test: Scale for the assessment and rating of ataxia (SARA);   Device: JAMAR hand dynamometer;   Device: Vibratory sensibility testing;   Device: Sermes and Weinstein test;   Device: Weber test
Sponsor:   Brugmann University Hospital
Recruiting


A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil


Condition:   Multiple Sclerosis
Interventions:   Diagnostic Test: anti-aquaporin-4 antibody;   Diagnostic Test: anti-myelin oligodendrocyte glycoprotein
Sponsors:   Pontificia Universidade Católica do Rio Grande do Sul;   TEVA
Recruiting


Pilot Diet Study for Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Behavioral: Dietary Intervention;   Behavioral: Non-dietary Intervention Arm
Sponsor:   Icahn School of Medicine at Mount Sinai
Active, not recruiting


A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis Patients


Condition:   Multiple Sclerosis
Intervention:   Other: Effort reeducation program
Sponsor:   Lille Catholic University
Not yet recruiting


Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Other: Nine Hole Test;   Device: Triple Stimulation Technique
Sponsor:   Brugmann University Hospital
Recruiting


Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Biological: Ublituximab;   Drug: Placebo
Sponsor:   TG Therapeutics, Inc.
Active, not recruiting


Pathological Basis of MRI Signal Changes in Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:  
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting


Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Drug: ponesimod;   Drug: teriflunomide
Sponsor:   Actelion
Active, not recruiting


MEsenchymal StEm Cells for Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Drug: Mesenchymal stem cells;   Drug: Suspension media
Sponsor:   University Hospital, Toulouse
Recruiting


Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension


Condition:   Multiple Sclerosis
Intervention:   Other: Observational Cognitive assessments
Sponsors:   Clinique Neuro-Outaouais;   CogState Ltd.
Completed


Physical Telerehabilitation in Veterans With Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:   Device: Multiple Sclerosis Home Automated Telemanagement (MS HAT) system
Sponsors:   University of Maryland;   Baltimore VA Medical Center
Completed


Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis


Condition:   Multiple Sclerosis
Intervention:   Other: cognitive remediation program: REHACOP
Sponsor:   University of Deusto
Completed


Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis


Condition:   Multiple Sclerosis
Interventions:   Drug: Interferon beta-1a i.m. injections;   Drug: Fingolimod oral capsules;   Drug: Placebo oral capsule;   Drug: Placebo i.m. injection
Sponsor:   Novartis Pharmaceuticals
Active, not recruiting

Refine Your Search Advanced Search